Effect of Bariatric Surgery on Intima Media Thickness: A Systematic Review and Meta-Analysis.
atherosclerosis
bariatric surgery
coronary heart disease
intima-media thickness
meta-analysis
obesity
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
13 Oct 2022
13 Oct 2022
Historique:
received:
22
08
2022
revised:
07
10
2022
accepted:
10
10
2022
entrez:
27
10
2022
pubmed:
28
10
2022
medline:
28
10
2022
Statut:
epublish
Résumé
Obesity, and in particular extreme obesity, as a global health problem is an important risk factor for many diseases, including atherosclerotic cardiovascular disease (ACVD). Bariatric surgery might stop or slow atherogenesis by decreasing excessive weight in the early stages of atherogenesis, by suppressing low-grade systemic inflammation as well as by inhibiting oxidative stress and endothelial dysfunction. The aim of this meta-analysis was to provide an answer to whether bariatric surgery has a significant effect on intima-media thickness (IMT) which is a surrogate marker of early atherosclerosis and has a good correlation with atherosclerotic coronary heart disease. A systematic literature search in PubMed, Scopus, Embase, and Web of Science as well as grey literature was performed from inception to 1 July 2022. The meta-analysis was performed using Comprehensive Meta-Analysis (CMA) V3 software. Overall, the estimate of effect size was measured by a random effects meta-analysis. To account for the heterogeneity of studies regarding study design, characteristics of the populations, and treatment duration, a random-effects model (using the DerSimonian-Laird method) and the generic inverse variance weighting approach were used. To assess the existence of publication bias in the meta-analysis, the funnel plot, Begg's rank correlation, and Egger's weighted regression tests were used. The meta-analysis of 30 trials, including 1488 subjects, demonstrated a significant decrease in IMT after bariatric surgery. The reduction in IMT was also robust in the leave-one-out sensitivity analysis. It must be stressed that the results of the random-effects meta-regression did not suggest any relationship between the changes in IMT and delta body mass index (BMI) or duration of follow-up after the bariatric surgery. However, the subgroup analyses showed a better IMT reduction after laparoscopic sleeve gastrectomy (LSG) when compared to Roux-en-Y gastric bypass (RYGB). Within a year, the IMT follow-up values showed a further improvement. Bariatric surgery significantly reduced IMT. Significant associations were found between the surgery type and IMT changes, as well as a significant effect of follow-up duration on the changes of IMT after bariatric surgery.
Sections du résumé
BACKGROUND
BACKGROUND
Obesity, and in particular extreme obesity, as a global health problem is an important risk factor for many diseases, including atherosclerotic cardiovascular disease (ACVD). Bariatric surgery might stop or slow atherogenesis by decreasing excessive weight in the early stages of atherogenesis, by suppressing low-grade systemic inflammation as well as by inhibiting oxidative stress and endothelial dysfunction. The aim of this meta-analysis was to provide an answer to whether bariatric surgery has a significant effect on intima-media thickness (IMT) which is a surrogate marker of early atherosclerosis and has a good correlation with atherosclerotic coronary heart disease.
METHODS
METHODS
A systematic literature search in PubMed, Scopus, Embase, and Web of Science as well as grey literature was performed from inception to 1 July 2022. The meta-analysis was performed using Comprehensive Meta-Analysis (CMA) V3 software. Overall, the estimate of effect size was measured by a random effects meta-analysis. To account for the heterogeneity of studies regarding study design, characteristics of the populations, and treatment duration, a random-effects model (using the DerSimonian-Laird method) and the generic inverse variance weighting approach were used. To assess the existence of publication bias in the meta-analysis, the funnel plot, Begg's rank correlation, and Egger's weighted regression tests were used.
RESULTS
RESULTS
The meta-analysis of 30 trials, including 1488 subjects, demonstrated a significant decrease in IMT after bariatric surgery. The reduction in IMT was also robust in the leave-one-out sensitivity analysis. It must be stressed that the results of the random-effects meta-regression did not suggest any relationship between the changes in IMT and delta body mass index (BMI) or duration of follow-up after the bariatric surgery. However, the subgroup analyses showed a better IMT reduction after laparoscopic sleeve gastrectomy (LSG) when compared to Roux-en-Y gastric bypass (RYGB). Within a year, the IMT follow-up values showed a further improvement.
CONCLUSIONS
CONCLUSIONS
Bariatric surgery significantly reduced IMT. Significant associations were found between the surgery type and IMT changes, as well as a significant effect of follow-up duration on the changes of IMT after bariatric surgery.
Identifiants
pubmed: 36294377
pii: jcm11206056
doi: 10.3390/jcm11206056
pmc: PMC9605301
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Obes Surg. 2021 Mar;31(3):1055-1061
pubmed: 33123869
Obes Surg. 2021 Oct;31(10):4461-4469
pubmed: 34319469
Obes Rev. 2022 Aug;23(8):e13481
pubmed: 35692179
Obes Surg. 2009 Mar;19(3):339-44
pubmed: 19083071
Autoimmun Rev. 2018 Aug;17(8):821-835
pubmed: 29885537
Diabetes Metab Syndr Obes. 2020 Feb 04;13:247-256
pubmed: 32099431
Atherosclerosis. 2022 May;348:25-35
pubmed: 35398698
Eur Heart J. 2022 May 21;43(20):1955-1969
pubmed: 35243488
Surg Obes Relat Dis. 2022 Aug;18(8):1074-1086
pubmed: 35717432
Circ J. 2014;78(4):977-85
pubmed: 24572586
Eur Heart J. 2021 Sep 7;42(34):3388-3403
pubmed: 34333589
Obes Surg. 2020 Mar;30(3):851-859
pubmed: 31925727
Lipids Health Dis. 2018 Jun 20;17(1):145
pubmed: 29925393
Atherosclerosis. 2022 Aug;354:23-40
pubmed: 35816927
Wien Klin Wochenschr. 2010 Mar;122(5-6):159-64
pubmed: 20361379
Oxid Med Cell Longev. 2021 Dec 06;2021:4136071
pubmed: 34912496
Surg Obes Relat Dis. 2005 Mar-Apr;1(2):81-5
pubmed: 16925219
Obesity (Silver Spring). 2019 Jan;27(1):68-74
pubmed: 30516353
Obes Surg. 2021 Feb;31(2):738-745
pubmed: 33188623
Obes Surg. 2022 May;32(5):1563-1569
pubmed: 35237906
Circ Res. 2014 Jan 17;114(2):233-5
pubmed: 24436424
Inflamm Res. 2012 Aug;61(8):789-807
pubmed: 22588278
Obesity (Silver Spring). 2013 Oct;21(10):1960-5
pubmed: 23512491
Obes Surg. 2021 Aug;31(8):3541-3547
pubmed: 33844173
Biometrics. 2000 Jun;56(2):455-63
pubmed: 10877304
Ren Fail. 2019 Nov;41(1):131-138
pubmed: 30909780
BMJ. 2013 Oct 22;347:f5934
pubmed: 24149519
Int J Obes (Lond). 2016 Mar;40(3):395-402
pubmed: 26388348
PLoS One. 2022 Jul 12;17(7):e0268716
pubmed: 35819948
Obes Surg. 2017 May;27(5):1145-1151
pubmed: 27812790
Obes Surg. 2004 May;14(5):589-600
pubmed: 15186624
Niger J Clin Pract. 2016 May-Jun;19(3):344-8
pubmed: 27022797
Kardiol Pol. 2020 Aug 25;78(7-8):674-680
pubmed: 32301596
JID Innov. 2021 Oct 13;2(1):100064
pubmed: 35024685
J Diabetes Complications. 2014 Jul-Aug;28(4):517-22
pubmed: 24685364
Pharmacol Res. 2015 Sep;99:329-36
pubmed: 26192349
J Physiol Pharmacol. 2019 Dec;70(6):
pubmed: 32084651
Nutr Metab Cardiovasc Dis. 2018 May;28(5):501-509
pubmed: 29571589
Arch Med Sci. 2019 Oct;15(6):1365-1374
pubmed: 31749863
Heart. 2012 Dec;98(24):1763-77
pubmed: 23077152
Surg Obes Relat Dis. 2017 Sep;13(9):1530-1535
pubmed: 28363402
Curr Obes Rep. 2021 Sep;10(3):263-273
pubmed: 33964008
Arterioscler Thromb Vasc Biol. 1999 Apr;19(4):972-8
pubmed: 10195925
Nutr Hosp. 2013 Jul-Aug;28(4):1102-8
pubmed: 23889627
Int J Obes (Lond). 2012 Mar;36(3):363-8
pubmed: 21894159
Front Nutr. 2022 Jun 24;9:925619
pubmed: 35811945
Obes Surg. 2018 Dec;28(12):3935-3942
pubmed: 30030728
Angiology. 2018 Feb;69(2):120-129
pubmed: 28675103
Eur J Clin Invest. 2019 Jul;49(7):e13118
pubmed: 30972739
Obes Surg. 2020 Jun;30(6):2251-2258
pubmed: 32198617
Obes Surg. 2018 Apr;28(4):1040-1046
pubmed: 29043547
Obesity (Silver Spring). 2020 Sep;28(9):1663-1670
pubmed: 32776483
J Vasc Surg. 1999 Mar;29(3):503-10
pubmed: 10069915
Obes Surg. 2017 Feb;27(2):357-363
pubmed: 27389676
Diabetes Care. 2013 Nov;36(11):3793-802
pubmed: 24062328
Obes Facts. 2020;13(3):321-330
pubmed: 32388504
Surg Endosc. 2021 Nov;35(11):6006-6012
pubmed: 33048234
J Int Med Res. 2021 May;49(5):3000605211012569
pubmed: 34024182
Anatol J Cardiol. 2020 Mar;23(4):218-222
pubmed: 32235138
Surg Obes Relat Dis. 2020 Oct;16(10):1419-1428
pubmed: 32694041
Eur J Clin Invest. 2020 Apr 29;:e13256
pubmed: 32350849
J Clin Med. 2022 Jul 13;11(14):
pubmed: 35887817